Abaxis gets FDA clearance for CRP test

01/21/2010 | ABC News

Abaxis, a provider of blood analysis systems, said it has obtained an FDA marketing clearance for its C-Reactive Protein assay. The test, which complements the company's Piccolo Xpress system, can detect infections, inflammatory diseases, tissue injuries and abnormal cell growth in under 12 minutes, Abaxis said.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC